| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |